|Title||Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.|
|Publication Type||Journal Article|
|Year of Publication||2017|
|Authors||Parikh, S, Goldstein, A, Karaa, A, Koenig, MKay, Anselm, I, Brunel-Guitton, C, Christodoulou, J, Cohen, BH, Dimmock, D, Enns, GM, Falk, MJ, Feigenbaum, A, Frye, RE, Ganesh, J, Griesemer, D, Haas, R, Horvath, R, Korson, M, Kruer, MC, Mancuso, M, McCormack, S, Raboisson, MJosee, Reimschisel, T, Salvarinova, R, Saneto, RP, Scaglia, F, Shoffner, J, Stacpoole, PW, Sue, CM, Tarnopolsky, M, Van Karnebeek, C, Wolfe, LA, Cunningham, ZZolkipli, Rahman, S, Chinnery, PF|
|Date Published||2017 Jul 27|
The purpose of this statement is to provide consensus-based recommendations for optimal management and care for patients with primary mitochondrial disease. This statement is intended for physicians who are engaged in the diagnosis and management of these patients. Working group members were appointed by the Mitochondrial Medicine Society. The panel included members with several different areas of expertise. The panel members utilized surveys and the Delphi method to reach consensus. We anticipate that this statement will need to be updated as the field continues to evolve. Consensus-based recommendations are provided for the routine care and management of patients with primary genetic mitochondrial disease.GENETICS in MEDICINE advance online publication, 27 July 2017; doi:10.1038/gim.2017.107.
|Alternate Journal||Genet. Med.|